Percutaneous Tibial Neuromodulation (PTNM) restores bladder function* without the side effects of medication† or the potential need to self-catheterize.1 While the NURO device was not used in the study, since it delivers equivalent stimulation as the device used, a user can expect similar performance.
PTNM, delivered by the Medtronic NURO™ system, is a safe and effective office-based treatment for overactive bladder (OAB). Delivered with an external neurostimulator, PTNM expands your options for OAB patients.2
Restored bladder function is defined as a measurable reduction in urinary frequency and/or urinary incontinence episodes following treatment.
The most common side effects are temporary and include mild pain or skin inflammation at or near the stimulation site.
Peters, K. M., S. A. Macdiarmid, et al. (2009). "Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial." J Urol 182(3): 1055-1061.
Kobashi K, Khandwala S, MacDiarmid S, et al. A Prospective Study to Evaluate Efficacy with the NURO Percutaneous Tibial Neuromodulation System in Drug Naïve Patients with overactive bladder syndrome (OAB). Presented at the American Urological Association 2018 Annual Meeting. Journal of Urology. 2018;199(4) Supplement, Page e987.